Covovax Heterologous Booster Dose

The Central drug regulatory authority, Drugs Controller General of India (DCGI), has given the green light for the market authorization of Serum Institute of India’s Covid-19 vaccine, Covovax, as a heterologous booster dose for those who have already received two doses of Covishield or Covaxin.
Covovax is a recombinant protein-based vaccine that is manufactured through technology transfer from Novavax. It has received conditional marketing authorization from the European Medicines Agency and emergency-use listing from the World Health Organization (WHO) on December 17, 2021.

November 22, 2023 Lucy Mission
Lucy is a NASA space probe on a twelve-year voyage to eight distinct asteroids, including two main belt asteroids...
November 22, 2023 BharOs
BharOS is a home-grown mobile operating system (OS), similar to Android or iOS. These technologies enable smartphone users to...
November 22, 2023 Neglected Tropical Diseases...
NTDs are a category of illnesses that are particularly widespread in marginalized groups in Africa, Asia, and the Americas....